We are live on ! Find out more
PCM

Piermont Capital Management Portfolio holdings

AUM $211M
1-Year Est. Return 8.09%
This Fund
S&P 500
This Quarter Est. Return
+7.52%
1 Year Est. Return
-8.09%
3 Year Est. Return
+33.18%
5 Year Est. Return
+53.13%
10 Year Est. Return
–
AUM
$422M
AUM Growth
+$36M
Cap. Flow
+$16.2M
Cap. Flow %
3.84%
Top 10 Hldgs %
10%
Holding
310
New
74
Increased
75
Reduced
64
Closed
65

Top Buys

Rank Stock Value
1
MUSA icon
Murphy USA
MUSA
+$3.73M
2
SR icon
Spire
SR
+$3.35M
3
MSTR icon
Strategy Inc
MSTR
+$3.32M
4
TILE icon
Interface
TILE
+$3.31M
5
RPT
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
+$3.18M

Top Sells

Rank Stock Value
1
ALE
Allete
ALE
+$3.98M
2
SANM icon
Sanmina
SANM
+$3.55M
3
POR icon
Portland General Electric
POR
+$3.55M
4
TRMK icon
Trustmark
TRMK
+$3.48M
5
NWN icon
Northwest Natural Holdings
NWN
+$3.37M

Sector Composition

Rank Sector Weight
1 Financials 18.89%
2 Industrials 17.05%
3 Technology 12.96%
4 Consumer Discretionary 12.85%
5 Real Estate 9.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPRT icon
176
Copart
CPRT
$27.5B
$893K 0.21%
133,440
– –
SHOO icon
177
Steven Madden
SHOO
$3.55B
$892K 0.21%
38,736
+3,420
+10% +$79.8K
HA
178
DELISTED
Hawaiian Holdings, Inc.
HA
$888K 0.21%
18,269
+1,540
+9% +$69.9K
MYGN icon
179
Myriad Genetics
MYGN
$312M
$878K 0.21%
42,660
+9,410
+28% +$239K
OCFC icon
180
OceanFirst Financial
OCFC
$1.91B
$864K 0.2%
+44,865
New +$855K
BJRI icon
181
BJ's Restaurants
BJRI
$1.48B
$854K 0.2%
24,034
+2,040
+9% +$82.1K
SCMP
182
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$828K 0.2%
67,269
+5,770
+9% +$68K
URBN icon
183
Urban Outfitters
URBN
$6.59B
$817K 0.19%
23,680
– –
PCH
184
DELISTED
PotlatchDeltic
PCH
$808K 0.19%
+20,781
New +$780K
DHX icon
185
DHI Group
DHX
$173M
$804K 0.19%
101,927
+8,870
+10% +$64.7K
SUPN icon
186
Supernus Pharmaceuticals
SUPN
$2.77B
$785K 0.19%
31,741
-36,140
-53% -$818K
PPLI
187
People Inc
PPLI
$3.1B
$783K 0.19%
70,110
– –
SGMO
188
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$783K 0.19%
169,079
+14,460
+9% +$73.5K
VAR
189
DELISTED
Varian Medical Systems, Inc.
VAR
$740K 0.18%
8,473
– –
HII icon
190
Huntington Ingalls Industries
HII
$12.8B
$736K 0.17%
4,796
-1,754
-27% -$291K
ANSS
191
DELISTED
Ansys
ANSS
$733K 0.17%
7,910
– –
AVY icon
192
Avery Dennison
AVY
$13.4B
$723K 0.17%
9,290
– –
HRC
193
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$715K 0.17%
+11,530
New +$649K
STBZ
194
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
$715K 0.17%
+31,325
New +$697K
INGR icon
195
Ingredion
INGR
$6.58B
$697K 0.17%
5,240
– –
DGX icon
196
Quest Diagnostics
DGX
$26.3B
$696K 0.16%
8,220
– –
BMS
197
DELISTED
Bemis
BMS
$695K 0.16%
13,620
– –
JKHY icon
198
Jack Henry & Associates
JKHY
$11.1B
$691K 0.16%
8,080
– –
RVTY icon
199
Revvity
RVTY
$12.8B
$683K 0.16%
+12,180
New +$665K
NVR icon
200
NVR
NVR
$17B
$672K 0.16%
410
– –
6 7
8
9 10

Similar funds

WAM
Watermark Asset Management San Ramon, California $216M AUM 7.54% 1-Year Est. Return
GIM
Greystone Investment Management Cincinnati, Ohio $195M AUM 6.99% 1-Year Est. Return
PPC
Precision Path Capital New York $233M AUM
MA
Marshwinds Advisory St Simons Island, Georgia $187M AUM 1.79% 1-Year Est. Return
PC
Palo Capital Newport Beach, California $236M AUM 5.33% 1-Year Est. Return
HCG
HNA Capital Group Haikou, China $243M AUM 36.37% 1-Year Est. Return
WA
WealthTrust-Arizona Scottsdale, Arizona $172M AUM 6.58% 1-Year Est. Return
VAM
Visionary Asset Management Houston, Texas $252M AUM 3.81% 1-Year Est. Return

Piermont Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Piermont Capital Management held 310 positions worth $422M, up 9.3% from $386M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Piermont Capital Management deployed $16.2M of net new capital in Q3 2016, opening 74 new positions and adding to 75 existing holdings. Its largest new stake was Murphy USA: 49,881 shares worth $3.56M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Anika Therapeutics, an estimated $1.15M trimmed.

  • Piermont Capital Management's largest Q3 2016 buy was Murphy USA: 49,881 shares worth $3.56M.
  • Piermont Capital Management added most to Spire in Q3 2016, an estimated $3.35M increase.
  • Piermont Capital Management's biggest Q3 2016 reduction was Anika Therapeutics, cutting an estimated $1.15M.
  • Piermont Capital Management fully exited Allete in Q3 2016, selling an estimated $3.98M.
  • Piermont Capital Management's ten largest holdings make up 10% of its $422M portfolio in Q3 2016.
  • Piermont Capital Management opened 74 new positions and closed 65 in Q3 2016.
  • Piermont Capital Management's portfolio value rose 9.3% quarter-over-quarter to $422M.

Based on Piermont Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.